Clinician’s Guide to Prevention and Treatment of Osteoporosis
Top Cited Papers
Open Access
- 15 August 2014
- journal article
- guideline
- Published by Springer Science and Business Media LLC in Osteoporosis International
- Vol. 25 (10), 2359-2381
- https://doi.org/10.1007/s00198-014-2794-2
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- Health risks and benefits from calcium and vitamin D supplementation: Women's Health Initiative clinical trial and cohort studyOsteoporosis International, 2012
- Interventions for preventing falls in older people living in the communityEmergencias, 2012
- The effect of 3 versus 6 years of Zoledronic acid treatment of osteoporosis: A randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)Journal of Bone and Mineral Research, 2011
- Updated fracture incidence rates for the US version of FRAX®Osteoporosis International, 2009
- Vitamin D-deficiency and post-fracture changes in lower extremity function and falls in women with hip fracturesOsteoporosis International, 2008
- Cost-effective osteoporosis treatment thresholds: the United States perspectiveOsteoporosis International, 2008
- FRAX™ and the assessment of fracture probability in men and women from the UKOsteoporosis International, 2008
- Effects of Tamoxifen vs Raloxifene on the Risk of Developing Invasive Breast Cancer and Other Disease OutcomesThe NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 TrialJAMA, 2006
- Effects of Conjugated Equine Estrogen in Postmenopausal Women With HysterectomyJAMA, 2004
- Risks and Benefits of Estrogen Plus Progestin in Healthy Postmenopausal Women: Principal Results From the Women's Health Initiative Randomized Controlled TrialJAMA, 2002